IMCV:NASDAQiShares Morningstar Mid-Cap Value ETF Analysis

IMCV is trading at $86.94, modestly above its 20‑day SMA of $84.77, indicating short‑term upward momentum. The price also sits just above the 50‑day SMA ($86.44) and well over the 200‑day SMA ($81.76), reinforcing a neutral‑to‑bullish bias. RSI at 59.7 suggests the ETF is not yet overbought, leaving room for further gains. MACD shows a bullish crossover (line $0.147 above signal –$0.297) with a positive histogram, supporting the upside view. Technical support at $82.41 and resistance near $87.57 frame the near‑term price range, with current levels already approaching the ceiling. Volume is on an increasing trend, adding conviction to the technical signals.
Fundamentally, IMCV offers a low expense ratio of 0.06% and a dividend yield of about 2.06%, appealing for cost‑conscious value investors. The fund’s beta of 0.71 indicates lower volatility than the broader market, while 30‑day volatility sits at 13.2%, a manageable level for mid‑cap exposure. A max drawdown of –7.3% over the recent period reflects limited downside risk. The Fear & Greed Index at 87.77 (“Extreme Greed”) points to strong market optimism that could buoy value‑oriented mid‑caps. No tracking error and zero premium/discount further reduce tracking risk. Overall, the blend of modest technical strength, attractive cost structure, and defensive risk metrics makes IMCV a compelling addition for investors seeking mid‑cap value exposure.